Investigations of the metabolites of the trypanocidal drug melarsoprol

@article{Keiser2000InvestigationsOT,
  title={Investigations of the metabolites of the trypanocidal drug melarsoprol},
  author={J. Keiser and {\"O}. Ericsson and C. Burri},
  journal={Clinical Pharmacology \& Therapeutics},
  year={2000},
  volume={67}
}
Melarsoprol remains the first‐choice drug for trypanosomiasis (human African sleeping sickness). To contribute to the sparse pharmacologic data and to better understand the cause of the frequent serious adverse reactions, we investigated the metabolism of this 50–year‐old organoarsenic compound. 
Chemotherapy of human African trypanosomiasis: current and future prospects.
Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis
  • A. Nok
  • Biology, Medicine
  • Parasitology Research
  • 2003
Melarsoprol Resistance in African Trypanosomiasis.
Drugs and drug resistance in African trypanosomiasis.
  • V. Delespaux, H. D. de Koning
  • Medicine
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
  • 2007
Effective measures for controlling trypanosomiasis
  • A. Nok
  • Medicine
  • Expert opinion on pharmacotherapy
  • 2005
Problems for the chemotherapy of human African trypanosomiasis
  • M. Barrett
  • Medicine
  • Current opinion in infectious diseases
  • 2000
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 40 REFERENCES
Mel B in the treatment of human trypanosomiasis.
  • E. Friedheim
  • Biology, Medicine
  • The American journal of tropical medicine and hygiene
  • 1949
Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy.
African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis.
  • J. Pépin, F. Milord
  • Biology, Medicine
  • Transactions of the Royal Society of Tropical Medicine and Hygiene
  • 1991
...
1
2
3
4
...